These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31021987)

  • 1. Heating Injection Drug Preparation Equipment Used for Opioid Injection May Reduce HIV Transmission Associated With Sharing Equipment.
    Ball LJ; Venner C; Tirona RG; Arts E; Gupta K; Wiener JC; Koivu S; Silverman MS
    J Acquir Immune Defic Syndr; 2019 Aug; 81(4):e127-e134. PubMed ID: 31021987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sharing of Injection Drug Preparation Equipment Is Associated With HIV Infection: A Cross-sectional Study.
    Ball LJ; Puka K; Speechley M; Wong R; Hallam B; Wiener JC; Koivu S; Silverman MS
    J Acquir Immune Defic Syndr; 2019 Aug; 81(4):e99-e103. PubMed ID: 31021986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of skin infections with sharing of injection drug preparation equipment among people who inject drugs.
    Jawa R; Stein MD; Anderson B; Liebschutz JM; Stewart C; Phillips KT; Barocas JA
    Int J Drug Policy; 2021 Aug; 94():103198. PubMed ID: 33744668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New hepatitis C diagnoses in Ontario, Canada are associated with the local prescription patterns of a controlled-release opioid.
    Meyer M; Bondy L; Koivu S; Koval J; Scarffe AD; Silverman MS
    J Viral Hepat; 2020 Aug; 27(8):774-780. PubMed ID: 32187428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A controlled-release oral opioid supports S. aureus survival in injection drug preparation equipment and may increase bacteremia and endocarditis risk.
    Kasper KJ; Manoharan I; Hallam B; Coleman CE; Koivu SL; Weir MA; McCormick JK; Silverman MS
    PLoS One; 2019; 14(8):e0219777. PubMed ID: 31398210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Reported Injection Behaviors Following the Public Health Response to an HIV Outbreak Among People Who Inject Drugs: Indiana, 2016.
    Dasgupta S; Broz D; Tanner M; Patel M; Halleck B; Peters PJ; Weidle PJ; O'Donnell J; Amlung J; McAlister C; Chapman E; Bailey A; Burnett J; Duwve J
    AIDS Behav; 2019 Dec; 23(12):3257-3266. PubMed ID: 31313095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 transmission in injection paraphernalia: heating drug solutions may inactivate HIV-1.
    Clatts MC; Heimer R; Abdala N; Goldsamt LA; Sotheran JL; Anderson KT; Gallo TM; Hoffer LD; Luciano PA; Kyriakides T
    J Acquir Immune Defic Syndr; 1999 Oct; 22(2):194-9. PubMed ID: 10843535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple injections per injection episode: High-risk injection practice among people who injected pills during the 2015 HIV outbreak in Indiana.
    Broz D; Zibbell J; Foote C; Roseberry JC; Patel MR; Conrad C; Chapman E; Peters PJ; Needle R; McAlister C; Duwve JM
    Int J Drug Policy; 2018 Feb; 52():97-101. PubMed ID: 29278838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydromorphone and the risk of infective endocarditis among people who inject drugs: a population-based, retrospective cohort study.
    Silverman M; Slater J; Jandoc R; Koivu S; Garg AX; Weir MA
    Lancet Infect Dis; 2020 Apr; 20(4):487-497. PubMed ID: 31981474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased HIV diagnoses in West Virginia counties highly vulnerable to rapid HIV dissemination through injection drug use: a cautionary tale.
    Bradley H; Hogan V; Agnew-Brune C; Armstrong J; Broussard D; Buchacz K; Burton K; Cope S; Dawson E; De La Garza G; Gerard A; Granado M; Gupta R; Haddy L; Hoffman W; Johnson SD; Kirk N; Lee C; Lyss S; Mark-Carew M; Quilter L; Reynolds P; Rose B; Thompson A; Varella L; Weidle P; White B; Wills D; Young SA; Hoots BE
    Ann Epidemiol; 2019 Jun; 34():12-17. PubMed ID: 30967302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syringe sharing among people who inject drugs in London, Canada.
    Scheim AI; Bardwell G; Rachlis B; Mitra S; Kerr T
    Can J Public Health; 2018 Apr; 109(2):174-182. PubMed ID: 29981046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injecting equipment sharing and perception of HIV and hepatitis risk among injecting drug users in Budapest.
    Rácz J; Gyarmathy VA; Neaigus A; Ujhelyi E
    AIDS Care; 2007 Jan; 19(1):59-66. PubMed ID: 17129858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role of safer injection facilities in reducing HIV and hepatitis C infections and overdose mortality in the United States.
    Semaan S; Fleming P; Worrell C; Stolp H; Baack B; Miller M
    Drug Alcohol Depend; 2011 Nov; 118(2-3):100-10. PubMed ID: 21515001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US.
    Des Jarlais DC; Cooper HLF; Arasteh K; Feelemyer J; McKnight C; Ross Z
    PLoS One; 2018; 13(3):e0194799. PubMed ID: 29596464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding differences in HIV/HCV prevalence according to differentiated risk behaviors in a sample of PWID in rural Puerto Rico.
    Abadie R; Welch-Lazoritz M; Gelpi-Acosta C; Reyes JC; Dombrowski K
    Harm Reduct J; 2016 Mar; 13():10. PubMed ID: 26956029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of infective endocarditis among people who inject drugs: a retrospective, population-based time series analysis.
    Weir MA; Slater J; Jandoc R; Koivu S; Garg AX; Silverman M
    CMAJ; 2019 Jan; 191(4):E93-E99. PubMed ID: 30692105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parenteral transmission of HIV among injection drug users: assessing the frequency of multiperson use of needles, syringes, cookers, cotton, and water.
    McCoy CB; Metsch LR; Chitwood DD; Shapshak P; Comerford ST
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S25-9. PubMed ID: 9663620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of Injection-Related Risk Behaviors After Emergency Implementation of a Syringe Services Program During an HIV Outbreak.
    Patel MR; Foote C; Duwve J; Chapman E; Combs B; Fry A; Hall P; Roseberry J; Brooks JT; Broz D
    J Acquir Immune Defic Syndr; 2018 Apr; 77(4):373-382. PubMed ID: 29271829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between public injecting and drug-related harm among HIV-positive people who use injection drugs in a Canadian setting: A longitudinal analysis.
    Ickowicz S; Wood E; Dong H; Nguyen P; Small W; Kerr T; Montaner JSG; Milloy MJ
    Drug Alcohol Depend; 2017 Nov; 180():33-38. PubMed ID: 28865390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
    Morissette C; Cox J; De P; Tremblay C; Roy E; Allard R; Stephenson R; Graves L
    Int J Drug Policy; 2007 May; 18(3):204-12. PubMed ID: 17689367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.